HRT Financial’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.72M	Buy	626,922 +387,562	+162%	+$1.23M	0.01%	1719
2025 Q4	$885K	Buy	239,360 +81,499	+52%	+$263K	﹤0.01%	1791
2025 Q3	$418K	Buy	+157,861	New	+$305K	﹤0.01%	1985
2025 Q2	–	Sell	-669,829	Closed	-$964K	–	2900
2025 Q1	$964K	Buy	669,829 +109,284	+19%	+$201K	0.01%	1123
2024 Q4	$1.23M	Buy	+560,545	New	+$1.31M	0.01%	971
2024 Q2	–	Sell	-442,030	Closed	-$1.18M	–	2470
2024 Q1	$1.18M	Buy	442,030 +394,059	+821%	+$958K	0.01%	807
2023 Q4	$143K	Sell	47,971 -18,799	-28%	-$24.4K	﹤0.01%	1846
2023 Q3	$65K	Sell	66,770 -433,999	-87%	-$628K	﹤0.01%	1986
2023 Q2	$696K	Buy	500,769 +481,346	+2,478%	+$672K	0.01%	1176
2023 Q1	$30K	Sell	19,423 -433	-2%	-$2.23K	﹤0.01%	2157
2022 Q4	$123K	Sell	19,856 -26,339	-57%	-$188K	﹤0.01%	2033
2022 Q3	$309K	Buy	46,195 +12,729	+38%	+$87.4K	﹤0.01%	1977
2022 Q2	$212K	Buy	+33,466	New	+$190K	﹤0.01%	2223
2022 Q1	–	Sell	-235,475	Closed	-$1.18M	–	3313
2021 Q4	$1.18M	Buy	235,475 +50,791	+28%	+$407K	0.01%	984
2021 Q3	$2.23M	Buy	+184,684	New	+$2.69M	0.01%	668
2020 Q1	–	Sell	-6,825	Closed	-$406K	–	927
2019 Q4	$406K	Buy	+6,825	New	+$307K	0.02%	608